The PPAR-α pathway has also been shown to be involved in hepatitis and fibrosis and inhibit the activity of inflammatory transcription factors, including NF-κB and activating protein 1 (AP-1)69. The gene discussed is NFKB1; the disease is hepatitis A virus infection.